Malonyl-coa

Cross Reference

There are no associated biomedical information in the current reference collection.

Current reference collection contains 3249 references associated with Malonyl-coa in LipidPedia. Due to lack of full text of references or no associated biomedical terms are recognized in our current text-mining method, we cannot extract any biomedical terms related to diseases, pathways, locations, functions, genes, lipids, and animal models from the associated reference collection.

Users can download the reference list at the bottom of this page and read the reference manually to find out biomedical information.

Here are additional resources we collected from PubChem and MeSH for Malonyl-coa

Possible diseases from mapped MeSH terms on references

We collected disease MeSH terms mapped to the references associated with Malonyl-coa

MeSH term MeSH ID Detail
Placental Insufficiency D010927 6 associated lipids
Cytomegalovirus Infections D003586 7 associated lipids
Cleft Lip D002971 8 associated lipids
Myocardial Stunning D017682 10 associated lipids
Hypoglycemia D007003 13 associated lipids
Mitochondrial Myopathies D017240 13 associated lipids
Ketosis D007662 13 associated lipids
Angina Pectoris D000787 27 associated lipids
Hyperinsulinism D006946 27 associated lipids
Hypothyroidism D007037 32 associated lipids
Per page 10 20 | Total 20

PubChem Biomolecular Interactions and Pathways

NCBI Entrez Crosslinks

All references with Malonyl-coa

Download all related citations
Per page 10 20 50 100 | Total 927
Authors Title Published Journal PubMed Link
Zhou L et al. Metabolic response to an acute jump in cardiac workload: effects on malonyl-CoA, mechanical efficiency, and fatty acid oxidation. 2008 Am. J. Physiol. Heart Circ. Physiol. pmid:18083904
Sharma V et al. Metoprolol improves cardiac function and modulates cardiac metabolism in the streptozotocin-diabetic rat. 2008 Am. J. Physiol. Heart Circ. Physiol. pmid:18203848
Stanley WC et al. beta-Hydroxybutyrate inhibits myocardial fatty acid oxidation in vivo independent of changes in malonyl-CoA content. 2003 Am. J. Physiol. Heart Circ. Physiol. pmid:12969881
Onay-Besikci A et al. Relative importance of malonyl CoA and carnitine in maturation of fatty acid oxidation in newborn rabbit heart. 2003 Am. J. Physiol. Heart Circ. Physiol. pmid:12388233
Poirier M et al. Probing the link between citrate and malonyl-CoA in perfused rat hearts. 2002 Am. J. Physiol. Heart Circ. Physiol. pmid:12234788
Goodwin GW and Taegtmeyer H Improved energy homeostasis of the heart in the metabolic state of exercise. 2000 Am. J. Physiol. Heart Circ. Physiol. pmid:11009433
Chandler MP et al. Moderate severity heart failure does not involve a downregulation of myocardial fatty acid oxidation. 2004 Am. J. Physiol. Heart Circ. Physiol. pmid:15191896
Martin J et al. Nutritional stress exacerbates hepatic steatosis induced by deletion of the histidine nucleotide-binding (Hint2) mitochondrial protein. 2016 Am. J. Physiol. Gastrointest. Liver Physiol. pmid:26767982
Raney MA et al. AMPK activation is not critical in the regulation of muscle FA uptake and oxidation during low-intensity muscle contraction. 2005 Am. J. Physiol. Endocrinol. Metab. pmid:15547141
Taylor EB et al. Long-chain acyl-CoA esters inhibit phosphorylation of AMP-activated protein kinase at threonine-172 by LKB1/STRAD/MO25. 2005 Am. J. Physiol. Endocrinol. Metab. pmid:15644453
Lehtihet M et al. Glibenclamide inhibits islet carnitine palmitoyltransferase 1 activity, leading to PKC-dependent insulin exocytosis. 2003 Am. J. Physiol. Endocrinol. Metab. pmid:12684219
Assifi MM et al. AMP-activated protein kinase and coordination of hepatic fatty acid metabolism of starved/carbohydrate-refed rats. 2005 Am. J. Physiol. Endocrinol. Metab. pmid:15956049
Steinberg GR et al. AMPK expression and phosphorylation are increased in rodent muscle after chronic leptin treatment. 2003 Am. J. Physiol. Endocrinol. Metab. pmid:12441311
Guo W et al. Aging results in paradoxical susceptibility of fat cell progenitors to lipotoxicity. 2007 Am. J. Physiol. Endocrinol. Metab. pmid:17148751
Vavrova E et al. Muscle expression of a malonyl-CoA-insensitive carnitine palmitoyltransferase-1 protects mice against high-fat/high-sucrose diet-induced insulin resistance. 2016 Am. J. Physiol. Endocrinol. Metab. pmid:27507552
Sebastián D et al. CPT I overexpression protects L6E9 muscle cells from fatty acid-induced insulin resistance. 2007 Am. J. Physiol. Endocrinol. Metab. pmid:17062841
Roepstorff C et al. Malonyl-CoA and carnitine in regulation of fat oxidation in human skeletal muscle during exercise. 2005 Am. J. Physiol. Endocrinol. Metab. pmid:15383373
Miura S et al. Marked phenotypic differences of endurance performance and exercise-induced oxygen consumption between AMPK and LKB1 deficiency in mouse skeletal muscle: changes occurring in the diaphragm. 2013 Am. J. Physiol. Endocrinol. Metab. pmid:23695215
Gao S et al. Important role of ventromedial hypothalamic carnitine palmitoyltransferase-1a in the control of food intake. 2013 Am. J. Physiol. Endocrinol. Metab. pmid:23736540
Frøsig C et al. Reduced malonyl-CoA content in recovery from exercise correlates with improved insulin-stimulated glucose uptake in human skeletal muscle. 2009 Am. J. Physiol. Endocrinol. Metab. pmid:19190265